Acted as a Rule 3 Adviser, Financial Adviser and Broker to Diurnal Group PLC

News

Read

Panmure Gordon was delighted to act as a Rule 3 Adviser, Financial Adviser and Broker to Diurnal Group PLC for the recommended cash acquisition by Neurocrine Biosciences for c.£48m.

Panmure Gordon’s team included: Freddy Crossley, Emma Earl, Rupert Dearden and Mark Rogers.

Freddy Crossley

Managing Director, Head of Healthcare

Emma Earl

Managing Director, Healthcare, Investment Banking

Rupert Dearden

Managing Director, Corporate Broking Services

Acted as a Rule 3 Adviser, Financial Adviser and Broker to Diurnal Group PLC

Freddy Crossley

Emma Earl

Rupert Dearden

Other insights like this

Keeping the world moving – Businesses that move goods from A to B had an excellent pandemic as supply chains stuttered. But what happens next?

Companies roundup: Finsbury Group, Boohoo, Deliveroo and Melrose

Appointed Joint Broker to Mears Group plc

Appointed as Sole Corporate Broker

Sole Sponsor, Joint Financial Adviser and Joint Broker

Litigation arm weighs down Close Brothers

Joint Rule 3 Adviser and Joint Financial Adviser to Civitas Social Housing plc

Appointed as Sole Corporate Broker and Financial Adviser